Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial

  • Juan V Luciano, Francesco D’Amico, Marta Cerdà-Lafont, María T Peñarrubia-María, Martin Knapp, Antonio I Cuesta-Vargas, Antoni Serrano-Blanco, Javier García-Campayo
  • Arthritis Research & Therapy, October 2014, Springer Science + Business Media
  • DOI: 10.1186/s13075-014-0451-y

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Antonio I Cuesta-Vargas